BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL (Public limited company)
BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0475.471.036. It was founded on 13-08-2001. Its registered office is in Ghent. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 1 201 783 and a profit of € 615 041. These accounts report 8.9 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.
Information last updated on 14-10-2026.
Company information
Key figures of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 615 041+292 % | € 156 990+140 % | € 65 528-78 % | € 291 274 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 1 201 783+105 % | € 586 742+37 % | € 429 752+18 % | € 364 224 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 3 692 187-24 % | € 4 847 523+45 % | € 3 333 047+27 % | € 2 628 445 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 1 388 6120 % | € 1 395 393-18 % | € 1 706 178-5 % | € 1 801 167 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 8.9-39 % | 14.6-24 % | 19.3-3 % | 19.9 |
Financial estimate
- 1 Shareholders
- 1 Board links
Similar companies
Other companies in the same activity in Ghent.
| Company | Town |
|---|---|
| BASF Agricultural Solutions Belgium | 9052 Gent |
| VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY | 9052 Gent |
| VIXEN BIOSYSTEMS | 9052 Gent |
| FUJIREBIO EUROPE | 9052 Gent |
| DEVGEN | 9052 Gent |
| Eurofins Amatsigroup | 9052 Gent |
| ABLYNX | 9052 Gent |
| Legend Biotech Belgium | 9052 Gent |
Frequently asked questions
Is BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL still active? Yes. The Crossroads Bank for Enterprises lists BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL as active.
What is the VAT number of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL? The VAT number of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL is BE 0475.471.036.
When was BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL founded? BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL was founded on 13-08-2001.
What is the address of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL? The current registered office of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL is Rijvisschestraat 118, 9052 Gand.
When did BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL last file annual accounts? The latest annual accounts of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL were filed on 06-10-2026.
Does BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL file its annual accounts on time? BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2025.
How many employees does BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL have? BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL employs 8.9 full-time equivalents according to its most recent annual accounts.
Is BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL financially healthy? Addrly gives BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL profitable? The annual accounts of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL for 2025 show a profit of € 615 041.
What is the equity of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL? The equity of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL was € 1 201 783 at the close of the 2025 financial year.
Who are the directors of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL? The annual accounts of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL record 1 mandate. The name, role and dates are visible with a free account.
Can BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL receive Peppol e-invoices? Yes. BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL is registered on the Peppol network and can receive structured electronic invoices.
What does BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL do? The main activity of BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL is: Scientific research and development.